Actively Recruiting
Evaluation of Treatment Patterns and Adherence in Early HER2-positive Breast Cancer After Decentralizing Care in Serbia
Led by Hoffmann-La Roche · Updated on 2026-10-08
100
Participants Needed
10
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating how a decentralized treatment model affects treatment adherence among participants with early-stage HER2-positive breast cancer. The study compares two groups one where participants do not experience increased travel burden for adjuvant therapy, and another where participants must travel from secondary to tertiary centers for treatment. The goal is to understand how travel impacts adherence and quality of life in routine clinical practice without study-mandated interventions. Participants are assigned to one of four cohorts based on their treatment history and residence. Some receive adjuvant therapy at secondary or tertiary centers, depending on their pathological response after neoadjuvant therapy or if they missed neoadjuvant therapy and had surgery first. All decisions about treatment occur as part of usual care, with no interventions imposed by the study. Throughout the study, participants treatment adherence, completion rates, delays in dosing, travel burden, and quality of life are observed and recorded. Various measures include travel burden comparisons between groups, changes in quality of life scores, and timing of neoadjuvant therapy, surgery, and adjuvant treatment initiation. The study follows participants for up to 2.25 years to assess these outcomes under real-world conditions.
CONDITIONS
Brief Title
A Study to Assess Treatment Patterns and Treatment Adherence in Early HER2-positive Breast Cancer Participants After Treatment Decentralization
Research Team
R
Reference Study ID Number: ML46477 https://forpatients.roche.com/ No attachments to email below.
F
Fastest response: use the inquiry form. https://www.gene.com/contact-us/submit-medical-inquiry
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here